chrisvoncsefalvay/vaers-outcomes huggingface dataset:
feeling nauseous; stomach pain; stomach was burning; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: unknown), via an unspecified route of administration on 20Jan2021 at single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient initially asked if the nausea and stomach pain that she experienced after getting the first dose of the Covid vaccine is a normal side effect. The patient reported that she received the first dose of the Covid vaccine yesterday (20Jan2021) and a few hours after she started feeling nauseous. She added that during the night she felt her like her stomach was burning and felt even more nauseous. She felt nauseous at night and today (21Jan2021). The patient asked she can take Prevacid or Tums or Pepto bismol or if there's a contraindication like there is with taking Tylenol or Motrin. The patient reported having read that taking Tylenol or Motrin may interfere with the vaccine and she wants to know if an antacid will have the same effect. The patient does not want to go to her HCP (healthcare professional). She just does not want anything to affect the efficacy of the first dose. The other part is she knows that achiness or fever can be a side effect, but she did not indicate if she experienced that. The outcome of events was unknown. This case is non-serious.  Information on the lot/batch number has been requested.
Tightness on sternum as if ringing a towel. Heaviness on sternum as if someone was sitting on my chest. Irradiating feel on sternum as if I applied 10x the strength of icy hot for 7 days after Pfizer vaccine, dose 1.
self-discovered sub-clavicular lymph node swelling in 1 node only-no pain.  No issues with this and as a nurse I am reporting  so this can be tracked as a side effect of this vaccine.  Will be self-monitoring this.
Crawling feeling under skin all over body.; Tingling and numbness in different areas of the body.; Tingling and numbness in different areas of the body.; Nausea; Dizziness; Elevated blood pressure; This is a spontaneous report from a contactable nurse, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 59267-1000-1) via an unspecified route of administration in the left arm on 28Sep2021 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included vitamin d nos (VITAMIN D) and one a day prenatal vitamin (unspecified); both for unknown indication from an unknown date and unknown if ongoing. On 05Oct2021, the patient experienced crawling feeling under skin all over body, tingling and numbness in different areas of the body, nausea, dizziness and elevated blood pressure. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events crawling feeling under skin all over body, tingling and numbness in different areas of the body, nausea, dizziness, elevated blood pressure were unknown at the time of this report.
Rash with elevate bumps, left shoulder, lymph nodes on right and left groin, rash and bumps on 3&4 left fingers, right & left Scilla.
Client presented at vaccination site on 11/17/21. The client reported he received a 1st dose Moderna COVID vaccine on 01/26/21 (lot #: 042120A) and a 2nd dose Moderna COVID vaccine on 02/26/21 (lot #: 001A21A) both at Health Center. Client reported within 45 minutes after receiving 1st dose Moderna COVID vaccine, he reported he felt difficulty breathing (shortness of breath (SOB) and his throat closing. On 01/26/21, he told his daughter drove him to urgent care and the urgent care allergist doctor gave him oral Benadryl with help and gave him Benadryl spray and oral pill to use at home. Client did not follow up with PCP after developing symptoms or after the urgent care visit. At 1659, PHN took his vitals: BP (automatic) 163/100, HR 45, O2 Sat. 99%, and at 1701, retook his BP (manual) 138/86. He reported he had no reactions to his 2nd dose Moderna COVID vaccine. He reported he had prostate cancer two years ago and not taking any medicines for it at present time. He told he is seeing the urologist every six months and seeing his PMD every six months for check-up. Client reported he took oral Benadryl 50 mg at 1600 today. He denied any other known allergies or any other chronic illnesses. At 1715, he decided not to wait for PHN to send for the medical consult and declined to schedule an appointment for his request for Moderna COVID booster vaccine. At 1715, Moderna COVID booster vaccine was not administered to client, and he left the vaccination site without providing his contact information. PHN didn?t send medical consult to clinical project coordinators since client left the site. But PHN will keep his medical consult information in case client plans to come back to get his Moderna COVID booster vaccine at vaccination site.
7cm localized reaction erythema, warmth, and swelling starting on 3/14/18, treated with cephalexin, ZYRTEC, and ice on 3/15/18.
About 24 hours after receiving the vaccine, I developed a headache at the base of my skull and some mild joint pain in my left hand. The joint pain lasted <1 day, the headache lasted ~1.5 days.
*Moderna*  Headache that has lasted 3 days along with a stiff neck on the left side.
Pt presented to the ER with left arm swelling and pain after getting a vaccination on Monday 3/15/13. Seen at ER on 03/28/13 at 12PM, mother notes arm swelled up several hours after the shot was given. Warm to touch since then. Pt started on Clindamycin antibiotics.
Information had been received on 19-APR-2017 from a lawyer regarding a case in litigation. It was alleged in litigation that a female patient of unknown age was inoculated with ZOSTAVAX vaccine (dose, route, site of administration, lot # and expiration date were not provided) on or about 13-DEC-2014 at a medical center, as recommended for routine adult health maintenance for the prevention of shingles. The patient's medical history, concurrent conditions and concomitant medication were not provided. The lawyer reported, the ZOSTAVAX vaccine did not prevent shingles as intended, but rather caused patient to contract a persistent strain of Herpes Zoster. On or about 02-MAR-2016, the patient was treated at a hospital medical center for a painful rash that was diagnosed as shingles.  On or about 16-MAR-2016, the patient was treated again at the hospital medical center for a worsening condition, which was determined to be post-herpetic neuralgia.  Post-herpetic neuralgia is a painful and chronic condition caused by the residual nerve damage after the contracting shingles.  While shingles and post-herpetic neuralgia are chronic and incurable conditions, the patient has been prescribed methylprednisolone oral (MEDROL DOSEPAK) and hydrocodone bitartrate (NORCO) to manage her symptoms.  As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain and suffering and other damages. This is one of several reports from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1704USA009733:
A non-serious spontaneous report of weakness, left foot weak and wobbly, hard time walking, and vomiting has been received from a consumer concerning a four-year-old male, subsequent to receiving FLUMIST. This case will be submitted in accordance with MedImmune's FLUMIST post-marketing commitment for the indicated population of 2 years to 59 months of age. Neither relevant medical history nor concomitant medications have been reported for this patient. On 11-Nov-2011, the patient received the first dose of FLUMIST. On 12-Nov-2011, the patient vomited a few times. The patient also had cetirizine on 12-Nov-2011. On the morning of 14-Nov-2011, the patient complained that his left foot felt weak and wobbly and he was having a hard time walking. He was taken to the emergency room on 14-Nov-2011 and diagnosed with weakness. Per the reporter, "he is walking fine now." The event of hard time walking resolved. The outcome for the events of left foot weak and wobbly and vomiting was unknown.
Employee on vacation, returned to work not feeling well.  Rapid test done with positive results for Covid
On day 7 started with fever & rash; rash spots were quarter size & smaller when not resolved - sent to hospital on 5-17-11 - no Dx at hosp - sent home on steroids.
Severe ongoing Lupus flare. Hip pain, back pain, shoulder pain, hand twist pain, hair loss, scalp sores, initia lly given up to 5mg. Prednisone daily to control flare. Methotrexate increased over course of year mg until an episode of leukopenia. (7.5.-22.5mg). Had to pause because I developed shingles. Without methotrexate symptoms returned. After 3 weeks acyclovir returned to methotrexate. Symptoms are better controlled with methotrexate but not in remission.
This is a spontaneous report from a contactable consumer. A 72-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EL9269) via an unspecified route of administration on 11Feb2021 at single dose for COVID-19 immunisation. Relevant medical history and concomitant medications were not reported. 2-3 days after vaccine (also reported as a day or 2) the patient started itching on her hip around to her back, described as patch of red upper hip area and her stomach and back were constantly itching. On a day or a few days after the vaccine she also had redness and edema in eyes (really red and swollen), she had a hard time opening her eyes and this occurred 2-3 times. There were no bumps it was just a reddish patch. Her upper hip area was the reddened area and the itching moved into her stomach and back. Second dose was scheduled for 04Mar2021.   No follow-up attempts are possible. No further information is expected.
This spontaneous report was received from a nurse and refers to a 25 year old patient of unknown gender. The patient's medical history was not reported. On 27-OCT-2015, the patient was vaccinated with a dose of ZOSTAVAX 0.65 ml, subcutaneously, lot # L012039, expiration date reported as 07-JUL-2016 (site of administration was not reported) instead of intended VARIVAX (Merck). No adverse effects were reported. Additional information has been requested.
Patient received first Pfizer COVID-19 vaccine during a well child office visit 6/30/2022. Patient's parent was called to schedule the second injection a month later and patient was inadvertently scheduled into the Moderna template for the second injection instead of Pfizer. Moderna COVID-19 vaccine was administered, after which patient's parent heard staff say "Moderna" while preparing to fill out the vaccination card. Provider was consulted and stated there was no contraindication, that this is a common occurrence as supply of what a person received initially is sometimes limited at locations around the nation. Patient's provider advised that patient should receive a Pfizer dose in two months to complete the series as if she had received Pfizer for all three vaccinations. Patient's parent was contacted and understood there was no contraindications and to schedule in two months for Pfizer.
Fever; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 28-May-2021 and was forwarded to Moderna on 28-May-2021.    Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On an unknown date, the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) outcome was unknown. Not Provided          Concomitant product use was not provided. No treatment was reported.
I had swelling in my left leg/foot that very noticeable and uncomfortable. I also started swelling in my right leg in the same area but wasn?t as bad as my left side.  The swelling made me feel like I was having a really bad flare/muscle spasms which lasted for 3-4 days. I am still having some discomfort, the swelling has gotten better but my left foot still feels more sensitive than usual.  I also had headaches, chills, stomach ache, and some slight aches at injection site.   Treatment- I just put my feet up and iced when I could tolerate while minimizing any prolonged standing or walking. I also took Advil to help the swelling
FEVER, CHEST PAIN THAT HAS NOW LASTED 8 DAYS, SOB THAT HAS NOW LASTED 8 DAYS,  CHEST TIGHTNESS THAT HAS NOW LASTED 8 DAYS. HEADACHE
As soon as she injected the vaccine into my arm I immediately felt a burning sensation go down the inside of my arm to my wrist. It lasted about 5 minutes. I felt fine the rest of the day. The next day I developed a burning sensation in my tongue, mouth throat and chest. Then weakness in my chest and dificulting breathing. It is Saturday April 10, 2021 and the symptoms still come and go. The burning sensations mostly at night. The chest weakness and breathing issues seem to be in the morning and when I exercise. These symptoms are not as bad as they were initially but still present. I am unable to get an answer when I ask if the burning down my are is normal when getting a vaccine. No one else that I have talked with has experienced this symptom.  I emailed my doctor she suggested taking tylenol.
FLUARIX 2007-08 0.5ML ADULT DOSE INADVERTENTLY ADMINISTERED TO NEWBORN BABY.  HEPATITIS B VACCINE IS WHAT NURSE WAS TRYING TO ADMINISTER.
Severe headaches; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Feb2021 at 11:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included SERTRALINE, taken for an unknown indication from an unknown date and unknown if ongoing. On 28Feb2021, the patient experienced severe headaches. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of severe headache and included treatment with unspecified medicine. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severe headaches was not recovered at the time of this report.   No follow-up attempts are required, information about lot/batch number cannot be obtained. No further information is expected.
skin sensitivity; loss of memory; skin is peeling off/peeling of skin on fingers; He works a lot with his hands and it has been bothering him; reports skin rashes on his butt and skin; This spontaneous case was reported by a consumer and describes the occurrence of SENSITIVE SKIN (skin sensitivity), AMNESIA (loss of memory), SKIN EXFOLIATION (skin is peeling off/peeling of skin on fingers), DISCOMFORT (He works a lot with his hands and it has been bothering him) and RASH (reports skin rashes on his butt and skin) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SENSITIVE SKIN (skin sensitivity), AMNESIA (loss of memory), SKIN EXFOLIATION (skin is peeling off/peeling of skin on fingers), DISCOMFORT (He works a lot with his hands and it has been bothering him) and RASH (reports skin rashes on his butt and skin). At the time of the report, SENSITIVE SKIN (skin sensitivity), AMNESIA (loss of memory), SKIN EXFOLIATION (skin is peeling off/peeling of skin on fingers) and RASH (reports skin rashes on his butt and skin) outcome was unknown and DISCOMFORT (He works a lot with his hands and it has been bothering him) had not resolved.            No concomitant drug details were reported.  Treatment information included an unspecified rash medicine and antibiotics.
Information was received on 14-MAR-2017 from a health care worker concerning and unknown number of unspecified patients. No medical history, concomitant medications or patient demographics were reported. The unspecified patients were administered improperly stored vaccines on unknown dates, starting after 01-JUN-2015. There were several different sets of excursion conditions with different vaccine involved. The nurse confirmed that while many of the vaccines lots are now expired, all improperly stored doses were not expired at the time of administration. No adverse effects were reported. The lot of GARDASIL 9 involved in the temperature excursion was lot: L016428, expires 30-JUN-2017. Other vaccines involved in the temperature excursion were PNEUMOVAX 23 (MARRS# 1703USA014563), RECOMBIVAX HB (MARRS# 1703USA014564), PEDVAXHIB (MARRS#1703USA014567), VARIVAX (MARRS# 1703USA014566), GARDASIL (MARRS# 1703USA007376). Follow-up information was received on 20-MAR-2017 from the reporter. The GARDASIL 9 vaccine lot L016428, expires 30-JUL-2017, doses were administered on 22-OCT-2015, 17-NOV-2015, 01-DEC-2015, 16-DEC-2015, 17-DEC-2015, 22-DEC-2015, 05-JAN-2016, 22-JAN-2016, 03-FEB-2016, 03-FEB-2016, 08-FEB-2016, 23-FEB-2016, 23-FEB-2016, 01-MAR-2016, 05-MAR-2016, 05-MAR-2016, 07-APR-2016, 05-MAY-2016, 13-MAY-2016, 07-JUN-2016 and 06-JUL-2016. Dose and injections sites not reported. No patient identifiers were provided. The lot was out of range for 265 hours, 30 minutes. Additional information has been requested. This is one of several reports by the same reporter.
Red, itchy area about 6x4 left arm;  severe cold and sleepy started next day and lasted  about 8 hours then went away.  Had no fever.  Later about 10 pm I got up to go to bathroom and my legs just gave out.  I could not move my legs or feet at all.  Called paramedics who got me up and walked me for at least 30 minutes.  I was very weak and unsteady.  I did improve slowly.  By morning I could walk cautiously.   Seem to be ok now.
Injection site soreness X 48  hours Narrative:  Injection site soreness lasted 48 hours.  Other Relevant History:
started feeling very cold around 8 Pm. After warm shower, hair was wet and was shaking from chills around 11 PM for about 30 minutes.  Went to sleep, and strong headache upon waking up (10:30 AM)
chest heaviness Narrative:  Patient received first dost of Pfizer COVID19 vaccine on 2/13/21.  When contacted on 3/5/21 to schedule second dose, declined to schedule due to reaction. On 3/8/21, patient's wife called and reported patient had had a reaction  and was recommended to received the Janssen vaccine. When called back to confirm symptoms, patient reported lips swelling and chest heaviness. He stated he did not seek emergent care and these symptoms resolved on their own.
Pt recvd 3 doses of Engerix-B JUL90, AUG90 & JAN91 & did not achieve protective antibody titers;
I have felt bad for over a week with body aches, fever and nausea chills non stop. for 8 days now
PATIENT PREVIOUSLY RECIEVED 2 DOSES OF PFIZER VACCINE (12/30/2020-LOT EJ1685 AND 1/20/2021-LOT EL3249). PRESCRIBER WAS NOTIFIED AND PATIENT HAS NOT EXPEREINCED ANY ADVERSE EVENTS TO DATE.
Fever to 101, body aches, chills, weakness and nausea for 24 hours
Patient is  barely under the age of 12 but was given the 12 yr old dose. by my overlooking his age on the form. I have followed up with the patient and all is well. Not even much arm soreness.
Patient called store the following morning stating her throat was closed/swelled. She contacted her physician and was told to take Claritin and to go to hospital if needed. She was better, but said throat raw with clear mucous.
Areas around the vaccination administration site began to itch followed by edema and arrhythmia. Site is warm to touch. Located on posterior L arm.
Pt recvd series of 3 Engerix-B vax on 05OCT90, 14NOV90 & 01MAR91; when tested @ completion of series was a non-responder & not protected;
A large, red circle around the site of the injection that swelled and was itchy. Later experienced other smaller sites of irritation on the left and right elbows, right hand, and feet.
Initial and follow up information has been received from a health professional for Merck Pregnancy Registry, concerning a 24 year old female patient who had an allergy to aspirin and had an abnormal cervical smear on 28-FEB-2008 which showed atypical cells. Patient was positive for human papilloma virus (exact stain was not known). On 07-MAR-2008 she was vaccinated IM with her first dose of GRADASIL (lot # 655504/0052X). It was reported that there was no concomitant medication. The home pregnancy test showed that the patient was pregnant. The medical assistant mentioned that the patient was going to have an office visit on 18-Mar-2008. In follow up information from the doctor's office it was reported that her last menstrual period was 15-FEB-2008 and expected delivery date would be 21-NOV-2008. On 23-MAR-2008 patient had an elective abortion which was five weeks after the LMP. The outcome of the event was unknown. Upon internal review elective termination of pregnancy was determined to be an other important medical event. Additional information is not expected.
Patient stated she experienced rash and swelling of the throat. Patient stated she took Benadryl after reaction appeared apparent  and it seemed to help the reaction
Patient experienced excruciating pain in arm several hours after PNEUMOVAX administration.  Patient still has some soreness and has been using ALEVE; EXCEDRIN; ice and a heating pad.
A sales representative reported that a 4 month old male received Prevnar, Hib-Titer, Orimune, and Diphtheria, Tetanus and Pertussis on 03/15/01. On 03/16/01, he experienced a seizure which resolved within 20 minutes. The patient was hospitalized that same day and was discharged on 03/19/01. Follow up info was received on 03/26/01 from the sales representative indicated the child developed a low grade fever the day of the vaccination for which the child was given Tylenol. the next day, the child was hospitalized for twenty minute episode of status epilepticus which required treatment with Ativan.